Validation of preoperative variables and stratification of patients to help predict benefit of cytoreductive nephrectomy in the targeted therapy ERA [PDF]
, 2017 Kim, Eric H +4 more
core +2 more sources
Corrigendum to "Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521]. [PDF]
Int J Infect Dis, 2021 Pandit A +6 more
europepmc +1 more source
Successful treatment of therapy-resistant metastatic Crohn's desiase with infliximab [PDF]
, 2004 CASTIGLIONE, FABIANA +5 more
core +1 more source
Intralesional Interferon Alfa-2b Versus Cryotherapy for Common Warts on the Hands and Feet: A Randomized, Open-Label, Controlled Trial. [PDF]
J Cosmet DermatolJin Y, Shen X.
europepmc +1 more source
Phase II Trial of Interleukin-12 Followed by Interferon Alfa-2b in Patients with Metastatic Malignant Melanoma: Results from CALGB 500001 (Alliance). [PDF]
Cancer Immunol ResLiu A +6 more
europepmc +1 more source
Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b. [PDF]
Rom J Ophthalmol, 2020 Rocha-de-Lossada C +5 more
europepmc +1 more source